PT Kalbe Farma Tbk Overview
Valuation check: PTKFF's ROE is 12.09%, below the Healthcare sector average of 22.01%.
Get informed when a big investor buys or sells
+ Follow12.09%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, PTKFF shows a ROE of 12.09%. That is below the Healthcare sector average of 22.01%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average ROE is about 22.01%. PT Kalbe Farma Tbk is at 12.09%, which is lower that average. That is roughly 45.1% below the sector mean. Use the comparison chart on this page to see how PTKFF stacks up against individual peers as well.
Check the historical chart to see whether PTKFF's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare PT Kalbe Farma Tbk with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has PT Kalbe Farma Tbk's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 12.09%) with ownership activity and broader fundamentals.
The Healthcare average ROE is about 22.01%, while PTKFF is at 12.09%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
